(Reuters) — More than a decade after becoming paralyzed from the neck down, Erik Sorto has been unable to perform even the simplest of daily tasks.
Neuromodulation/Neurostimulation
Weight loss: 1st commercial implant of EnteroMedics’ Maestro device
St. Jude launches Prodigy spinal cord stimulator in Canada
Neuronetics raises $34m for anti-depression device
Neuronetics said it raised $34.3 million in an equity offering slated to help broaden the use of its anti-depression device that relies on magnetic stimulation of the brain.
Autonomic Technologies raises $38m in Series D round
Boston Scientific challenges Nevro patent
ImThera begins pivotal trial for Aura6000 sleep apnea implant
ImThera Medical said the 1st 2 U.S. patients in a clinical study of its Aura6000 sleep apnea therapy were successfully implanted with the device. The surgeries were performed by Dr. Sam Mickelson of Advanced Sleep Centers in Atlanta, Ga.
FDA OKs trial for StimGuard’s bladder implant
StimGuard said it won an investigational device exemption from the FDA for a clinical trial of its micro-size implantable device to treat overactive bladder syndrome. StimGuard said its system uses a small injectable microchip and an external transmitter and requires no invasive surgery to implant. The trial is slated to begin in summer 2015.